You have 9 free searches left this month | for more free features.

Condition

Non-small Cell Lung Cancer (2)

Metastatic Lung Cancer (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

Sponsor

Daiichi Sankyo, Inc. (2)

Gustave Roussy, Cancer Campus, Grand Paris (1)

Collaborator

AstraZeneca (2)

Daiichi Sankyo, Inc. (1)

Intervention

ds-1062a (3)

docetaxel (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

ds-1062a

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Lung Cancer Trial in Villejuif (DS-1062a)

Recruiting

Metastatic Lung Cancer

DS-1062a

Villejuif, France

Gustave Roussy

Jun 17, 2021

NSCLC Trial in Worldwide (DS-1062a)

Active, not recruiting

Non-small Cell Lung Cancer

DS-1062a

Phoenix, Arizona
+82 more

Jul 27, 2022

NSCLC Trial in Worldwide (DS-1062a, Docetaxel)

Recruiting

Non-small Cell Lung Cancer

DS-1062a
Docetaxel

Chandler, Arizona
+203 more

Jun 9, 2022